← Back to All Filings

SCHEDULE 13G/A Filing: Kymera Therapeutics, Inc.

Not Yet AnalyzedOctober 27, 2026 at 5:31:01 PM EDT

Kymera Therapeutics, Inc.

$KYMRSCHEDULE 13G/ACIK: 0001815442

Subscribe to track KYMR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

SCHEDULE 13G/A Filing

Company: Kymera Therapeutics, Inc. Filed: 2026/10/27

View Filing

Topics:#SECFiling#SCHEDULE13GA#StockAlert

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.